The reason for these conflicting observations is still unclear, but higher levels of serum IL-18 beyond the threshold, a second factor that triggers hyperinflammation, and/or other regulatory or anti-inflammatory cytokines, such as IL-37 and IL-10, are probably indispensable for defining MAS/HLH predisposition. The gene discussed is IL10; the disease is hemophagocytic syndrome.